After many years of clinical trial failures in Alzheimer’s disease, pharma sees some positive results – although caution is recommended.

Does a medicine’s price consistently track with its benefits and value? Not in the US, according to a study.

A vaccine using mRNA demonstrates potential for broad influenza protection.

A new not-for-profit company will manufacture important generics in the US

A new comedy series focuses on pharma and a clinical trial gone wrong.

After many years of clinical trial failures in Alzheimer’s disease, pharma sees some positive results – although caution is recommended.

Women, like men, want good medicines that have been tested in clinical trials involving fair representation of both sexes.

We examine the most commercially important biotherapeutics now, and in the future.

Making cancer drugs cheaper and more effective – with a paper “coffee” filter.

What is the current state of pharma contract development and manufacturing?